# Switching Medication to Treat Schizophrenia

> **NCT00044655** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 219 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Olanzapine
- **DRUG:** Ziprasidone
- **DRUG:** Quetiapine
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00044655
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044655, "Switching Medication to Treat Schizophrenia". Retrieved via AI Analytics 2026-08-09 from https://api.ai-analytics.org/clinical/NCT00044655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*